Edition:
India

EyePoint Pharmaceuticals Inc (EYPT.OQ)

EYPT.OQ on NASDAQ Stock Exchange Global Market

2.11USD
16 Jul 2018
Change (% chg)

$-0.04 (-1.86%)
Prev Close
$2.15
Open
$2.14
Day's High
$2.14
Day's Low
$2.07
Volume
17,917
Avg. Vol
108,112
52-wk High
$2.87
52-wk Low
$0.93

Chart for

About

Eyepoint Pharmaceuticals, Inc., formerly pSivida Corp, develops drug delivery products primarily for the treatment of chronic eye diseases. The Company has developed three products for treatment of back-of-the-eye diseases, which include Medidur for posterior segment uveitis, its lead product candidate that is in pivotal Phase... (more)

Overall

Beta: 1.34
Market Cap(Mil.): $48.36
Shares Outstanding(Mil.): 39.32
Dividend: --
Yield (%): --

Financials

BRIEF-EyePoint Pharmaceuticals Reports Q3 Loss Per Share $0.15

* EYEPOINT PHARMACEUTICALS REPORTS FISCAL THIRD QUARTER 2018 RESULTS

09 May 2018

BRIEF-Eyepoint Pharmaceuticals U.S. Patent And Trademark Office Has Issued Notices Of Allowance For Two Patents Covering DEXYCU

* U.S. PATENT AND TRADEMARK OFFICE HAS ISSUED NOTICES OF ALLOWANCE FOR TWO PATENTS COVERING DEXYCU Source text for Eikon: Further company coverage:

12 Apr 2018

Earnings vs. Estimates